Aultman Hospital Adds Layer of Safety with Evolv Technology
July 19 2023 - 7:00AM
Business Wire
AI-Powered Weapons Detection Integrates With
Hospital’s Genetec Technology
Evolv Technology (NASDAQ: EVLV), the leader in AI-based weapons
detection security screening, today announced its partnership with
Aultman Hospital in Ohio. The hospital will use Evolv’s
state-of-the-art Evolv Express® screening solution at two
high-traffic areas in the building.
Evolv Express uses powerful sensor technology with artificial
intelligence (AI) to provide safer, more accurate threat detection
at unprecedented volume and speed. Aultman Hospital, located in
Canton, Ohio, will use two systems– one at its main entrance and
another for its emergency department.
“We needed a weapons detection solution that wouldn’t impact
people trying to get to work or to an appointment, and Evolv was
the perfect answer,” said Darin B. Baad, security coordinator at
Aultman Hospital. “Unfortunately, hospitals are facing increased
levels of violence, and we need to take steps to protect our
environment without stopping and checking every person individually
as they walk in.”
Evolv Express allows people to move through security screening
without having to always open bags or empty pockets, preventing
backups at entrances. The technology distinguishes between threats
and most everyday items people carry. According to Aultman
Hospital, within the first ten hours of installing the new systems,
a number of prohibited items were found, including a gun, a taser,
and knives, and nurses and staff have praised the hospital for
prioritizing safety.
Aultman procured its Evolv Express systems from Johnson
Controls, an Evolv distribution partner. Evolv’s Genetec
integration also allows the technology to work seamlessly with the
other security measures Aultman Hospital has in place, including
security cameras and access control.
“This is an exciting partnership because Aultman Hospital is the
first to take advantage of Evolv’s Genetec integration capability,”
said Jason Grellner, vice president, healthcare for Evolv. “More
and more hospitals are looking to add weapons detection screening
for their facilities, and we believe Evolv will help provide some
peace of mind to patients, doctors, nurses, and hospital
staff.”
Aultman Hospital joins a number of other healthcare facilities
using Evolv as they strive to create a safer environment for
patients, visitors and staff and respond to the growing concern
healthcare workers face when it comes to workplace violence.
About Evolv Technology
Evolv Technology (NASDAQ: EVLV) is transforming human security
to make a safer, faster, and better experience for the world’s most
iconic venues and companies as well as schools, hospitals, and
public spaces, using industry leading artificial intelligence
(AI)-powered weapons detection and analytics. Its mission is to
transform security to create a safer world to work, learn, and
play. Evolv has digitally transformed the gateways in places where
people gather by enabling seamless integration combined with
powerful analytics and insights. Evolv’s advanced systems have
scanned more than 600 million people, second only to the Department
of Homeland Security’s Transportation Security Administration (TSA)
in the United States. Evolv has been awarded the U.S. Department of
Homeland Security (DHS) SAFETY Act Designation as a Qualified
Anti-Terrorism Technology (QATT) as well as the Security Industry
Association (SIA) New Products and Solutions (NPS) Award in the Law
Enforcement/Public Safety/Guarding Systems category. Evolv
Technology®, Evolv Express®, Evolv Insights®, and Evolv Cortex AI®
are registered trademarks of Evolv Technologies, Inc. in the United
States and other jurisdictions. For more information, visit
https://evolvtechnology.com.
Forward-looking Statements
Certain statements in this press release may constitute
“forward-looking” statements and information, within the meaning of
Section 27A of the Securities Act of 1933, Section 21E of the
Securities Exchange Act of 1934, and the safe harbor provisions of
the U.S. Private Securities Litigation Reform Act of 1995 that
relate to our current expectations and views of future events. In
some cases, these forward-looking statements can be identified by
words or phrases such as “may,” “will,” “expect,” “anticipate,”
“aim,” “estimate,” “intend,” “plan,” “believe,” “potential,”
“continue,” “is/are likely to” or other similar expressions. These
forward-looking statements are subject to risks, uncertainties and
assumptions, some of which are beyond our control. In addition,
these forward-looking statements reflect our current views with
respect to future events or our Company’s performance and are not a
guarantee of future performance. Actual outcomes may differ
materially from the information contained in the forward-looking
statements as a result of a number of factors, including, without
limitation, the risk factors set forth in our Annual Report on Form
10-K for the year ended on December 31, 2022, that was filed with
the SEC on March 24, 2023, as may be updated in other filings we
make with the SEC, including our Quarterly Report on Form 10-Q for
the quarter ended on March 31, 2023 that was filed with the SEC on
May 10, 2023. These statements reflect management’s current
expectations regarding future events and operating performance and
speak only as of the date of this press release. You should not put
undue reliance on any forward-looking statements. Although we
believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee that future results,
levels of activity, performance and events and circumstances
reflected in the forward-looking statements will be achieved or
will occur. Except as required by law, we undertake no obligation
to update or revise publicly any forward-looking statements,
whether as a result of new information, future events or otherwise,
after the date on which the statements are made or to reflect the
occurrence of unanticipated events.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230719726322/en/
Media: Alexandra Smith Ozerkis
aozerkis@evolvtechnology.com
Investor: Brian Norris bnorris@evolvtechnology.com
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Jul 2023 to Jul 2024